Lyprinol reduces inflammation and improves lung function in a mouse model of allergic airways disease

Clinical and Experimental Allergy

Volumn 40, Issue 12, 2010, Pages 1785-1793

  Wood, L G ^a   Hazlewood, L C ^a   Foster, P S ^a   Hansbro, P M ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

3; Asthma; Eosinophil; Fish oil; Lyprinol; Th2 response

Indexed keywords

FISH OIL; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LYPRINOL; OMEGA 3 FATTY ACID; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BODY MASS; CYTOKINE RELEASE; DIET SUPPLEMENTATION; EOSINOPHIL; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION; LUNG LAVAGE; MALE; MOUSE; MUCOUS CELL; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; EOSINOPHILS; FATTY ACIDS, OMEGA-3; FISH OILS; INFLAMMATION; LIPIDS; LUNG; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; TH2 CELLS;

EID: 78349263400     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03503.x     Document Type: Article

References (51)

1. Rosenberg HF, Phipps S, Foster PS. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 2007; 119:1303-10.
2. Rhoden KJ, Barnes PJ. Effect of hydrogen peroxide on guinea-pig tracheal smooth muscle in vitro: role of cyclo-oxygenase and airway epithelium. Br J Pharmacol 1989; 98:325-30.
3. Katsumata U, Miura M, Ichinose M et al. Oxygen radicals produce airway constriction and hyperresponsiveness in anesthetized cats. Am Rev Respir Dis 1990; 141:1158-61.
4. Adler KB, Holden-Stauffer WJ, Repine JE. Oxygen metabolites stimulate release of high-molecular-weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via an arachidonic acid-dependent mechanism. J Clin Invest 1990; 85:75-85.
5. Doelman CJ, Leurs R, Oosterom WC et al. Mineral dust exposure and free radical-mediated lung damage. Exp Lung Res 1990; 16:41-55.
6. Tate RM, Vanbenthuysen KM, Shasby RM et al. Oxygen-radical-mediated permeability edema and vasoconstriction in isolated perfused rabbit lungs. Am Rev Respir Dis 1982; 126:802-6.
7. Hogan SP, Rosenberg HF, Moqbel R et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008; 38:709-50.
8. Black PN, Sharpe S. Dietary fat and asthma: is there a connection? Eur Respir J 1997; 10:6-12.
9. Calder PC. N-3 polyunsaturated fatty acids and immune cell function. Adv Enzyme Regul 1997; 37:197-237.
10. Lee TH, Hoover RL, Williams JD et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312:1217-24.
11. Fisher M, Levine PH. Effects of dietary omega 3 fatty acid supplementation on leukocyte free radical production. World Rev Nutr Diet 1991; 66:245-9.
12. Woods RK, Thien FC, Abramson MJ. Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev 2002; 3:001283.
13. Chatzi L, Torrent M, Romieu I et al. Diet, wheeze, and atopy in school children in Menorca, Spain. Pediatr Allergy Immunol 2007; 18:480-5.
14. Hodge L, Salome CM, Peat JK et al. Consumption of oily fish and childhood asthma risk. Med J Aust 1996; 164:137-40.
15. Laerum BN, Wentzel-Larsen T, Gulsvik A et al. Relationship of fish and cod oil intake with adult asthma. Clin Exp Allergy 2007; 37:1616-23.
16. Peat JK, Salome CM, Woolcock AJ. Factors associated with bronchial hyperresponsiveness in Australian adults and children. Eur Respir J 1992; 5:921-9.
17. Schwartz J, Weiss ST. Dietary factors and their relation to respiratory symptoms. The second national health and nutrition examination survey. Am J Epidemiol 1990; 132:67-76.
18. Tabak C, Wijga AH, De Meer G et al. Diet and asthma in Dutch school children (ISAAC-2). Thorax 2006; 61:1048-53.
19. Devereux G, Seaton A. Diet as a risk factor for atopy and asthma. J Allergy Clin Immunol 2005; 115:1109-17.
20. McKeever TM, Britton J. Diet and asthma. Am J Respir Crit Care Med 2004; 170:725-9.
21. Gibson RG, Gibson SL. Green-lipped mussel extract in arthritis. Lancet 1981; 1:439.
22. Murphy KJ, Mann NJ, Sinclair AJ. Fatty acid and sterol composition of frozen and freeze-dried New Zealand Green Lipped Mussel (Perna canaliculus) from three sites in New Zealand. Asia Pacific J Clin Nutr 2003; 12:50-60.
23. Murphy KJ, Mooney BD, Mann NJ et al. Lipid, FA, and sterol composition of New Zealand green lipped mussel (Perna canaliculus) and Tasmanian blue mussel (Mytilus edulis). Lipids 2002; 37:587-95.
24. Sinclair AJ, Murphy KJ, Li D. Marine lipids: overview "news insights and lipid composition of Lyprinol". Allergy Immunol (Paris) 2000; 32:261-71.
25. Emelyanov A, Fedoseev G, Krasnoschekova O et al. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 2002; 20:596-600.
26. Horvat JC, Starkey MR, Kim RY et al. Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J Allergy Clin Immunol 2010; 125:617-25.
27. Sinclair AJ, Murphy K, Li D. Marine lipids: overview 'new insights and lipid composition of lyprinol'. Allergie Immunol 2000; 22:261-71.
28. Tenikoff D, Murphy KJ, Le M et al. Lyprinol (stabilised lipid extract of New Zealand green-lipped mussel): a potential preventative treatment modality for inflammatory bowel disease. J Gastroenterol 2005; 40:361-5.
29. Shiels IA, Whitehouse MW Lyprinol: anti-inflammatory and uterine-relaxant activities in rats, with special reference to a model for dysmenorrhoea. Allergy Immunol (Paris) 2000; 32:279-83.
30. Whitehouse MW, Macrides TA, Kalafatis N et al. Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel. Inflammopharmacology 1997; 5:237-46.
31. Horvat JC, Beagley KW, Wade MA et al. Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med 2007; 176:556-64.
32. Asquith KL, Ramshaw HS, Hansbro PM et al. The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation. J Immunol 2008; 180:1199-206.
33. Preston JA, Esslifie AT, Horvat JC et al. Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae. Vaccine 2007; 25:8154-62.
34. Arm JP, Horton CE, Mencia-Huerta JM et al. Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 1988; 43:84-92.
35. Dry J, Vincent D. Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 1991; 95:156-7.
36. Kirsch CM, Payan DG, Wong MY et al. Effect of eicosapentaenoic acid in asthma. Clin Allergy 1988; 18:177-87.
37. Picado C, Castillo JA, Schinca N et al. Effects of a fish oil enriched diet on aspirin intolerant asthmatic patients: a pilot study. Thorax 1998; 43:93-7.
38. Thien FC, Mencia-Huerta JM, Lee TH. Dietary fish oil effects on seasonal hay fever and asthma in pollen-sensitive subjects. Am Rev Respir Dis 1993; 147:1138-43.
39. Halpern GM. Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol). Allergy Immunol (Paris) 2000; 32:272-8.
40. Marom Z, Shelhamer JH, Bach MK et al. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982; 126:449-51.
41. Laitinen LA, Laitinen A, Haahtela T et al. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 1993; 341:989-90.
42. Seki H, Tani Y, Arita M. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostaglandins Other Lipid Mediat 2009; 89:126-30.
43. Aoki H, Hisada T, Ishizuka T et al. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun 2008; 367:509-15.
44. Archer SL. Fish oil as a therapy for lung disease. Nutrition 1996; 12:372-4.
45. Cosgrove JP, Church DF, Pryor WA. The kinetics of the autoxidation of polyunsaturated fatty acids. Lipids 1987; 22:299-304.
46. Liu J, Yeo HC, Doniger SJ et al. Assay of aldehydes from lipid peroxidation: gas chromatography-mass spectrometry compared to thiobarbituric acid. Anal Biochem 1997; 245:161-6.
47. Zimmermann N, Hogan SP, Mishra A et al. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 2000; 165:5839-46.
48. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006; 24:147-74.
49. Grunig G, Warnock M, Wakil AE et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282:2261-3.
50. Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282:2258-61.
51. Mattes J, Yang M, Mahalingham S et al. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 2002; 195:1433-44.